Frontline Asciminib Combination in Chronic Phase CML

Clinical trial NCT03906292 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03906292
Sponsor: University of Jena
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia

Start date: 2019-08-19
Primary completion: 2027-03-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.